Abstract:Animals and animal models have been invaluable for our current understanding of human and animal biology, including physiology, pharmacology, biochemistry, and disease pathology. However, there are increasing concerns with continued use of animals in basic biomedical, pharmacological, and regulatory research to provide safety assessments for drugs and chemicals. There are concerns that animals do not provide sufficient information on toxicity and/or efficacy to protect the target population, so scientists are utilizing the principles of replacement, reduction, and refinement (the 3Rs) and increasing the development and application of new approach methods (NAMs). NAMs are any technology, methodology, approach, or assay used to understand the effects and mechanisms of drugs or chemicals, with specific focus on applying the 3Rs. Although progress has been made in several areas with NAMs, complete replacement of animal models with NAMs is not yet attainable. The road to NAMs requires additional development, increased use, and, for regulatory decision making, usually formal validation. Moreover, it is likely that replacement of animal models with NAMs will require multiple assays to ensure sufficient biologic coverage. The purpose of this manuscript is to provide a balanced view of the current state of the use of animal models and NAMs as approaches to development, safety, efficacy, and toxicity testing of drugs and chemicals. Animals do not provide all needed information nor do NAMs, but each can elucidate key pieces of the puzzle of human and animal biology and contribute to the goal of protecting human and animal health. Significance Statement Data from traditional animal studies have predominantly been used to inform human health safety and efficacy. Although it is unlikely that all animal studies will be able to be replaced, with the continued advancement in new approach methods (NAMs), it is possible that sometime in the future, NAMs will likely be an important component by which the discovery, efficacy, and toxicity testing of drugs and chemicals is conducted and regulatory decisions are made.

A Review on Alternative Methods to Experimental Animals in Biological Testing: Recent Advancement and Current Strategies

A Comprehensive Review on Redundancy usage of Animal models in Novel Drug testing

Alternatives of Animal Models for Biomedical Research: a Comprehensive Review of Modern Approaches

Progress and promise of alternative animal and non-animal methods in biomedical research

They See a Rat, We Seek a Cure for Diseases: The Current Status of Animal Experimentation in Medical Practice

The Implementation of the Three Rs in Regulatory Toxicity and Biosafety Assessment: The Indian Perspective

Technology progress of alternative to animal testing

Dogs and monkeys in preclinical drug development: the challenge of reducing and replacing

Reduction Strategies in Animal Research: A Review of Scientific Approaches at the Intra-experimental, Supra-experimental and Extra-experimental Levels

Protecting Human and Animal Health: The Road from Animal Models to New Approach Methods

Animal models in neuroscience with alternative approaches: Evolutionary, biomedical, and ethical perspectives

Poor Translatability of Biomedical Research Using Animals — A Narrative Review

Considering aspects of the 3Rs principles within experimental animal biology

Drug review process advancement and required manufacturer and contract research oraganization responses

Role of animal models in biomedical research: a review

A Brief History of Use of Animals in Biomedical Research and Perspective on Non-Animal Alternatives

The Usefulness of Systematic Reviews of Animal Experiments for the Design of Preclinical and Clinical Studies

Advances in Animal Models and Cutting-Edge Research in Alternatives: Proceedings of the Second International Conference on 3Rs Research and Progress, Hyderabad, 2021

Endeavours made by trade associations, pharmaceutical companies and regulators in the replacement, reduction and refinement of animal experimentation in safety testing of pharmaceuticals

Advances in Animal Models and Cutting-Edge Research in Alternatives: Proceedings of the Third International Conference on 3Rs Research and Progress, Vishakhapatnam, 2022

Review on In-vitro Techniques and In-vivo Animals Models for Screening Diabetes and Diabetic Complications